Venus Concept Inc Stock News

Reduction of outstanding debt by Madryn Asset Management continues to improve the Company's financial position Reduction of outstanding debt by Madryn Asset Management continues to improve the Company's financial position

TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, November 13, 2025.

Growing popularity of advanced cosmetic technologies, social media influence, and increasing aesthetic consciousness are fueling robust growth in the global cellulite treatment market. Growing popularity of advanced cosmetic technologies, social media influence, and increasing aesthetic consciousness are fueling robust growth in the global cellulite treatment market.

Venus Concept Inc. (NASDAQ:VERO ) Q2 2025 Earnings Conference Call August 14, 2025 5:00 PM ET Company Participants Domenic Della Penna - Executive VP & CFO Rajiv Kanishka Liyanaarchchie De Silva - CEO & Director Operator Good day, ladies and gentlemen, and welcome to the Second Quarter 2025 Earnings Conference Call for Venus Concept Inc. [Operator Instructions] Please note that this conference ...

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2025.

TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2025 financial results will be released after the market closes on Thursday, August 14, 2025.

Further reduction of outstanding debt by Madryn Asset Management improves the Company's balance sheet position Further reduction of outstanding debt by Madryn Asset Management improves the Company's balance sheet position

$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants